Guardant Health Statistics
Total Valuation
Guardant Health has a market cap or net worth of $6.88 billion. The enterprise value is $7.71 billion.
Important Dates
The last earnings date was Wednesday, July 30, 2025, after market close.
| Earnings Date | Jul 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Guardant Health has 124.71 million shares outstanding. The number of shares has increased by 2.95% in one year.
| Current Share Class | 124.71M |
| Shares Outstanding | 124.71M |
| Shares Change (YoY) | +2.95% |
| Shares Change (QoQ) | +0.20% |
| Owned by Insiders (%) | 4.13% |
| Owned by Institutions (%) | 97.65% |
| Float | 119.55M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.18 |
| Forward PS | 6.86 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 9.31 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.71
| Current Ratio | 3.71 |
| Quick Ratio | 2.74 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -150.23 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -19.57% |
| Return on Invested Capital (ROIC) | -24.30% |
| Return on Capital Employed (ROCE) | -42.10% |
| Revenue Per Employee | $410,118 |
| Profits Per Employee | -$204,759 |
| Employee Count | 2,021 |
| Asset Turnover | 0.56 |
| Inventory Turnover | 4.08 |
Taxes
In the past 12 months, Guardant Health has paid $1.07 million in taxes.
| Income Tax | 1.07M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +91.10% in the last 52 weeks. The beta is 1.44, so Guardant Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.44 |
| 52-Week Price Change | +91.10% |
| 50-Day Moving Average | 48.30 |
| 200-Day Moving Average | 41.26 |
| Relative Strength Index (RSI) | 68.43 |
| Average Volume (20 Days) | 2,973,694 |
Short Selling Information
The latest short interest is 9.40 million, so 7.54% of the outstanding shares have been sold short.
| Short Interest | 9.40M |
| Short Previous Month | 9.58M |
| Short % of Shares Out | 7.54% |
| Short % of Float | 7.86% |
| Short Ratio (days to cover) | 4.80 |
Income Statement
In the last 12 months, Guardant Health had revenue of $828.85 million and -$413.82 million in losses. Loss per share was -$3.35.
| Revenue | 828.85M |
| Gross Profit | 520.84M |
| Operating Income | -460.45M |
| Pretax Income | -490.27M |
| Net Income | -413.82M |
| EBITDA | -419.12M |
| EBIT | -460.45M |
| Loss Per Share | -$3.35 |
Full Income StatementBalance Sheet
The company has $522.81 million in cash and $1.33 billion in debt, giving a net cash position of -$811.35 million or -$6.51 per share.
| Cash & Cash Equivalents | 522.81M |
| Total Debt | 1.33B |
| Net Cash | -811.35M |
| Net Cash Per Share | -$6.51 |
| Equity (Book Value) | -305.48M |
| Book Value Per Share | -2.45 |
| Working Capital | 645.00M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$238.55 million and capital expenditures -$33.18 million, giving a free cash flow of -$271.73 million.
| Operating Cash Flow | -238.55M |
| Capital Expenditures | -33.18M |
| Free Cash Flow | -271.73M |
| FCF Per Share | -$2.18 |
Full Cash Flow StatementMargins
Gross margin is 62.84%, with operating and profit margins of -55.55% and -49.93%.
| Gross Margin | 62.84% |
| Operating Margin | -55.55% |
| Pretax Margin | -49.80% |
| Profit Margin | -49.93% |
| EBITDA Margin | -50.57% |
| EBIT Margin | -55.55% |
| FCF Margin | n/a |
Dividends & Yields
Guardant Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.95% |
| Shareholder Yield | -2.95% |
| Earnings Yield | -6.00% |
| FCF Yield | -3.94% |
Dividend DetailsAnalyst Forecast
The average price target for Guardant Health is $55.67, which is 0.93% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $55.67 |
| Price Target Difference | 0.93% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 18 |
| Revenue Growth Forecast (5Y) | 19.50% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Guardant Health has an Altman Z-Score of -1.23 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.23 |
| Piotroski F-Score | 4 |
